ENDP [NASD]
Endo International plc
Index- P/E- EPS (ttm)-2.92 Insider Own0.50% Shs Outstand233.88M Perf Week-48.87%
Market Cap127.94M Forward P/E1.02 EPS next Y0.57 Insider Trans0.00% Shs Float232.95M Perf Month-77.69%
Income-681.40M PEG- EPS next Q0.44 Inst Own82.30% Short Float15.07% Perf Quarter-81.36%
Sales2.93B P/S0.04 EPS this Y-584.60% Inst Trans1.84% Short Ratio5.28 Perf Half Y-91.41%
Book/sh-5.61 P/B- EPS next Y-37.53% ROA-8.20% Target Price1.33 Perf Year-89.88%
Cash/sh6.38 P/C0.09 EPS next 5Y- ROE75.30% 52W Range0.36 - 7.07 Perf YTD-84.63%
Dividend- P/FCF0.45 EPS past 5Y29.90% ROI-0.30% 52W High-91.82% Beta1.23
Dividend %- Quick Ratio1.60 Sales past 5Y-5.70% Gross Margin71.80% 52W Low59.83% ATR0.23
Employees3103 Current Ratio1.80 Sales Q/Q-9.10% Oper. Margin-3.80% RSI (14)19.07 Volatility52.06% 21.35%
OptionableYes Debt/Eq- EPS Q/Q-241.60% Profit Margin-24.80% Rel Volume4.96 Prev Close0.58
ShortableYes LT Debt/Eq- EarningsMay 05 AMC Payout- Avg Volume6.64M Price0.58
Recom3.00 SMA20-63.91% SMA50-72.33% SMA200-83.01% Volume0 Change0.00%
May-06-22Downgrade Piper Sandler Neutral → Underweight $3 → $1
Mar-02-22Downgrade Barclays Equal Weight → Underweight $5 → $2
Aug-31-21Downgrade Piper Sandler Overweight → Neutral $10 → $3
Apr-07-21Resumed RBC Capital Mkts Sector Perform $7
Jul-27-20Initiated Goldman Sell $3
Apr-24-20Initiated Citigroup Buy $7
Jan-03-20Upgrade Piper Jaffray Neutral → Overweight $5 → $7
Jul-15-19Downgrade Morgan Stanley Equal-Weight → Underweight
Jun-17-19Downgrade Citigroup Buy → Neutral
Jun-11-19Initiated Barclays Equal Weight
May-13-19Downgrade JP Morgan Neutral → Underweight
Mar-20-19Initiated SunTrust Buy
Mar-05-19Downgrade SVB Leerink Outperform → Mkt Perform
Nov-09-18Upgrade Canaccord Genuity Hold → Buy $16 → $20
Sep-11-18Upgrade Goldman Sell → Neutral
Aug-13-18Upgrade RBC Capital Mkts Sector Perform → Outperform
Aug-09-18Reiterated Stifel Hold $10 → $17
Jun-27-18Upgrade Citigroup Neutral → Buy
Apr-04-18Downgrade Mizuho Buy → Neutral $12 → $7
Feb-28-18Downgrade Gabelli & Co Buy → Hold
May-19-22 12:15PM  
May-18-22 04:45PM  
03:25PM  
May-16-22 09:05AM  
May-06-22 01:23PM  
12:16PM  
May-05-22 07:15PM  
04:30PM  
04:30PM  
04:15PM  
May-04-22 03:19PM  
May-03-22 12:10PM  
May-02-22 01:11PM  
07:55AM  
07:30AM  
Apr-28-22 06:00PM  
03:02PM  
07:30AM  
Apr-25-22 09:00AM  
Apr-20-22 05:23PM  
05:23PM  
Apr-19-22 02:21PM  
Apr-12-22 06:15PM  
05:00PM  
05:00PM  
Apr-04-22 06:00AM  
Apr-01-22 06:00PM  
Mar-30-22 12:43PM  
11:30AM  
Mar-28-22 07:30AM  
07:30AM  
Mar-24-22 04:58PM  
Mar-23-22 06:00PM  
Mar-15-22 06:00PM  
Mar-08-22 12:06PM  
Mar-03-22 04:30PM  
Mar-02-22 09:15AM  
Mar-01-22 04:45PM  
11:19AM  
Feb-28-22 04:15PM  
Feb-23-22 10:11AM  
Feb-21-22 03:01PM  
Feb-18-22 06:00PM  
Feb-14-22 09:59AM  
Feb-11-22 07:30AM  
Feb-08-22 12:10PM  
Feb-07-22 06:00PM  
07:30AM  
Feb-01-22 06:00PM  
09:30AM  
Jan-25-22 05:00PM  
05:00PM  
Jan-24-22 06:00PM  
Jan-20-22 06:15PM  
Jan-18-22 10:12AM  
07:52AM  
07:48AM  
07:00AM  
07:00AM  
Jan-17-22 07:30AM  
Jan-14-22 06:00PM  
Jan-13-22 07:30AM  
07:30AM  
Jan-12-22 12:20PM  
Jan-11-22 07:00AM  
07:00AM  
Jan-10-22 07:30AM  
Jan-06-22 06:00PM  
Jan-04-22 06:25PM  
05:00PM  
05:00PM  
Dec-30-21 10:58AM  
10:07AM  
Dec-28-21 12:04PM  
Dec-27-21 07:19AM  
Dec-23-21 02:19PM  
02:19PM  
02:11PM  
01:44PM  
01:25PM  
11:22AM  
06:00AM  
Dec-22-21 10:44AM  
Dec-16-21 10:26AM  
09:53AM  
Dec-15-21 02:54PM  
10:44AM  
10:23AM  
Dec-14-21 05:17PM  
Dec-08-21 11:28AM  
Dec-07-21 05:43PM  
10:14AM  
Dec-06-21 11:51AM  
11:45AM  
Dec-03-21 03:30PM  
Dec-02-21 05:37PM  
09:21AM  
Dec-01-21 01:52PM  
01:38PM  
10:06AM  
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Barry Patrick AEVP & Pres,Global Comm OpsMar 30Option Exercise0.0016,9570174,686Mar 31 04:09 PM
Maletta Matthew JosephEVP, CLO & Company SecretaryMar 30Option Exercise0.0034,4140361,264Mar 31 04:06 PM
Bradley Mark T.EVP, Chief Financial OfficerMar 30Option Exercise0.0010,7350104,534Mar 31 04:03 PM
Coleman BlaisePresident, CEOMar 30Option Exercise0.0035,9100432,203Mar 31 04:02 PM